MK-8669; AP23573; Ridaforolimus
572924-54-0
990.2
C53H84NO14P
DMF, DMSO, Ethanol
-20°C
Deforolimus is a small-molecule inhibitor of the mammalian target of rapamycin (mTOR). Blocking mTOR creates a starvation-like effect in cancer cells by interfering with cell growth, division, metabolism, and angiogenesis.
0.1 lbs
Substance Name:Changchuanmycin; FK-520; FR900520; Immunomycin; L 683590
CAS Number:104987-12-4
Substance Name:N-Debenzoyl-N-(t-butoxycarbonyl)-10-deacetyltaxol; Taxotere; RP-56976; NSC-628503
CAS Number:114977-28-5
Substance Name:N-Debenzoyl-N-(t-butoxycarbonyl)-10-deacetyltaxol; Taxotere; RP-56976; NSC-628503
CAS Number:114977-28-5
Substance Name:5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Substance Name:Coahibitor; FUT 175; Nafamastat
CAS Number:82956-11-4
Substance Name:N-Debenzoyl-N-(t-butoxycarbonyl)-10-deacetyltaxol; Taxotere; RP-56976; NSC-628503
CAS Number:114977-28-5
Substance Name:BSA fraction V
CAS Number:9048-46-8
Substance Name:NSC 79534; sodium vanadium oxide
CAS Number:13721-39-6
